Axplora
A German API manufacturing partner, delivering high quality active ingredients on time and at scale. The company is the result of a merger of Farmabios, Novasep and PharmaZell.
Axplora leverages its combined expertise and manufacturing capabilities across nine industrial sites in Europe and India, and an R&D facility in the USA.
The company offers CDMO solutions to innovators for their small molecule and biomolecular active pharmaceutical ingredients, as well as products that address lifestyle-induced respiratory, inflammatory and liver diseases.
Latest Axplora News & Features
19 October 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze